STOCK TITAN
  1. Home
  2. Financials
  3. BCTXL
  4. EPS (Diluted)

BriaCell Therapeutics Warrant expiring 2031 (BCTXL) EPS by Year

BCTXL NASDAQ

BriaCell Therapeutics Corp. Warrant expiring 2031 lost $6.97 per diluted share in fiscal year 2026. The table below carries 6 fiscal years, from 2021 to 2026, and the quarters BriaCell Therapeutics Corp. Warrant expiring 2031 has filed alongside them.

FY2026 annual
EPS (Diluted) -$6.97
Source SEC Filings (10-K/10-Q) Latest period FY2026, ended Jul 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

BCTXL EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2610-KFY2510-KFY2410-KFY2310-KFY2210-KFY2110-K
EPS (Diluted)-$6.97-$62.19-$43.68-$1.30n/m-$1.73N/A

BCTXL EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2610-KQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-Q
EPS (Diluted)-$1.24-$0.99-$2.58-$4.35N/A-$16.42-$23.31-$32.67-$0.07$1.61-$10.64-$0.50n/m

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More BriaCell Therapeutics Corp. Warrant expiring 2031 financials

Frequently Asked Questions

BriaCell Therapeutics Corp. Warrant expiring 2031 lost $6.97 per diluted share in fiscal year 2026.

BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) reported -$1.24 in diluted earnings per share in Q4 2026.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL) reported on that line in every period on record.